Logo
D

Dicerna Pharmaceuticals, Inc.

239 employees

Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Health Care
Genetics

Date founded

2007

Funding rounds raised

Total raised

$100M

from 14 investors over 14 rounds

D

Dicerna Pharmaceuticals, Inc. raised $100M on October 29, 2018

Investors: Cowen Inc.

D

Dicerna Pharmaceuticals, Inc. raised $70M on March 30, 2017

Investors: RA Capital Management, L.P., Domain Associates and Sky Ventures

D

Dicerna Pharmaceuticals, Inc. raised $60M on July 31, 2013

Investors: Domain Associates, Brookside Capital Inc, RA Capital Management, L.P., S.R. One Ltd, Abingworth, Sky Ventures and Omega Funds

D

Dicerna Pharmaceuticals, Inc. raised $4M on October 21, 2010

Investors: S.R. One Ltd

D

Dicerna Pharmaceuticals, Inc. raised $8.4M on July 15, 2008

Investors: Sky Ventures and Abingworth

FAQ